SANGUINE CORPORATION & SUBSIDIARY (A Development Stage Company) Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		266 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
REVENUES	$ 0	$ 0	$ 224,732
COST OF SALES	0	0	18,297
GROSS PROFIT	0	0	206,435
OPERATING EXPENSES
Professional fees	19,929	54,186	5,619,171
Research and development	0	10,870	1,991,260
Stock based compensation	0	984,975	986,775
Selling, general and administrative	43,250	42,087	3,113,748
Total Operating Expenses	63,179	1,092,118	11,710,954
LOSS FROM OPERATIONS	(63,179)	(1,092,118)	(11,504,519)
OTHER INCOME (EXPENSE)
Interest income	0	0	40,195
Interest expense	(23,399)	(4,352)	(759,858)
Gain (loss) on foreign currency exchange	0	0	(9,099)
Loss on cash deposit	0	0	(10,020)
Gain on settlement of debt	0	0	1,577,972
Total Other Income (Expense)	(23,399)	(4,352)	839,190
NET LOSS BEFORE PROVISION FOR INCOME TAX	(86,578)	(1,096,470)	(10,665,329)
PROVISION FOR INCOME TAX	0	0	0
NET LOSS	$ (86,578)	$ (1,096,470)	$ (10,665,329)
BASIC AND DILUTED LOSS PER SHARE	$ (0.01)	$ (0.16)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING -BASIC AND DILUTED	7,246,822	6,693,322